The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer.
 
Catharina Op't Hoog
No Relationships to Disclose
 
Niven Mehra
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; MSD Oncology (Inst); Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/Merck (Inst); Bristol Myers Squibb Foundation (Inst); Janssen-Cilag (Inst)
 
Anouk van Kleef
No Relationships to Disclose
 
Diederik Somford
Consulting or Advisory Role - Bayer (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Besins Healthcare (Inst); Blue Earth Diagnostics (Inst); Ipsen (Inst); Janssen-Cilag (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bayer (Inst)
 
Inge van Oort
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)
Research Funding - Astellas Pharma (Inst); Bayer (Inst)
 
Alex Imholz
No Relationships to Disclose
 
Paul Hamberg
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); MSD (Inst); Pfizer (Inst)
 
Nielka Van Erp
Research Funding - Astellas Pharma (Inst); Ipsen (Inst)
 
Emmy Boerrigter
No Relationships to Disclose